JAMA ophthalmology۲٬۰۲۶نمایه شده در PubMed
Kent Heberer, Adam P Bress, Steven Cogill, Ana I Maldonado, Sun H Kim, Shriram Nallamshetty, Ying Q Chen, Mei-Chiung Shih, Julie A Lynch, Jennifer S Lee
چکیده
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are considered safe, effective medications for type 2 diabetes (T2D) and weight loss, used by millions worldwide. While their cardiometabolic benefits are well established, emerging observations suggest a potential association between GLP-1RA use…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1001/jamaophthalmol.2025.6262